MARY TRUJILLO: Open Payments
NPI 1669407698 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$658 in 21 payments from 12 companies in 2025. Trend: 2023 $945 · 2024 $630 · 2025 $658
Food & beverage: $658
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 2 | $140 |
| Neurocrine BioSciences, Inc. | 1 | $116 |
| ACADIA Pharmaceuticals Inc | 4 | $87 |
| Eisai Inc. | 3 | $68 |
| ABBVIE INC. | 3 | $67 |
| Biogen, Inc. | 2 | $41 |
| GENZYME CORPORATION | 1 | $37 |
| CSL Behring | 1 | $26 |
| Lundbeck LLC | 1 | $24 |
| UCB, Inc. | 1 | $24 |
Products named: DAXXIFY, INGREZZA, NUPLAZID, Leqembi, BOTOX, VUMERITY, Hizentra, VYEPTI.
Industry payments across NM — which companies pay providers there.
